For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for intensive insulin therapy when used in conjunction with blood glucose monitoring and carb counting.
Scope of the Report:
In the last several years, global market of insulin pump developed smoothly, with an average growth rate of 5.2%. In 2016, global revenue of insulin pump is nearly 1218 M USD; the actual production is about 246 K units.
The global average price of insulin pump is in the decreasing trend, from 5256 USD/Unit in 2011 to 4936 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Insulin Pump includes normal and patch pump, and the proportion of normal in 2016 is about 82%. Insulin pump is widely used to treat Type I diabetes and Type II diabetes. The most proportion of insulin pump is used for Type I diabetes treatment, and the consumption proportion in 2016 is about 81%.
The worldwide market for Insulin Pump is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Insulin Pump in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Medtronic
- Johnson & Johnson
- Roche
- SOOIL
- Tandem Diabetes care
- Insulet Corp
- Valeritas
- Microport
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Normal
- Patch Pump
Market Segment by Applications, can be divided into
- Type I Diabetes
- Type II Diabetes
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Pump product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin Pump, with price, sales, revenue and global market share of Insulin Pump in 2017 and 2018.
Chapter 3, the Insulin Pump competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Pump breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Insulin Pump market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Insulin Pump sales channel, distributors, customers, research findings and conclusion, appendix and data source.